Anna, Kinga, Balázs, and Roland attended the EHDN Clinical Research Congress 2026, held on 22–24 October in Kraków, Poland. The biennial meeting of the European Huntington’s Disease Network brought together clinicians, researchers, patient advocates, and families affected by Huntington’s disease. The scientific program covered the HD therapeutic pipeline, clinical trial design, biomarkers, and genetic modifiers. One of the highlights was a keynote lecture by Nobel laureate Aaron Ciechanover on the ubiquitin–proteasome system, a topic closely connected to our work on proteostasis and autophagy in induced neuronal models of HD. All four of team members presented posters on their Huntington’s disease projects. Beyond the scientific discussions, the congress was also a valuable opportunity to hear directly from patients and families — an important reminder of who our research is ultimately for.
